Quarterly report [Sections 13 or 15(d)]

Schedule of Stock Option Activity (Details)

v3.26.3
Schedule of Stock Option Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Number of options, outstanding at beginning 30,481  
Weighted average exercise price, outstanding at beginning $ 521.40  
Weighted average contractual term in years 6 years 14 days 6 years 6 months
Aggregate intrinsic value beginning [1]  
Number of options, granted  
Weighted average exercise price, granted  
Number of options, exercised  
Weighted average exercise price, exercised  
Number of options, forfeited (850)  
Weighted average exercise price, forfeited $ 234.15  
Number of options, expired (4,668)  
Weighted average exercise price, expired $ 690.15  
Number of options, outstanding at ending 24,963 30,481
Weighted average exercise price, outstanding at beginning $ 499.65 $ 521.40
Aggregate intrinsic value ending [1]
Number of options, Exercisable at ending 20,472  
Weighted average exercise price, exercisable of ending $ 593.40  
Weighted average contractual term in years 5 years 6 months 29 days  
Aggregate intrinsic value ending [1]  
[1] The aggregate intrinsic value in the above table was calculated on the positive difference, if any, between the closing price per share of the Company’s common stock on September 30, 2026 of $2.33 and the split-adjusted per share exercise price of the underlying options.